P. N. Hawkins

Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction

M. Lythgoe, R. Ordidge, A. Price, 2013, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself

C. Sabin, M. Pepys, P. Hawkins, 2005, Circulation research.

Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy.

M. Rela, N. Heaton, M. Pepys, 1998, Transplantation.

DIAGNOSTIC RADIONUCLIDE IMAGING OF AMYLOID: BIOLOGICAL TARGETING BY CIRCULATING HUMAN SERUM AMYLOID P COMPONENT

M. Pepys, P. Hawkins, M. Myers, 1988, The Lancet.

The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.

M. Pepys, P. Hawkins, W. Hutchinson, 1994, The Journal of clinical investigation.

Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

T. Rademacher, M. Pepys, P. Hawkins, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology.

M. Pepys, P. Hawkins, C. Winearls, 1996, Kidney international.

Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

M. Pepys, P. Hawkins, R. Wootton, 1990, The Journal of clinical investigation.

Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component

M. Pepys, P. Hawkins, D. Sethi, 1991, The Lancet.